Lung Cancer Trial, Recruiting NCT01143480 Sponsor: National Institute of Environmental Health Sciences (NIEHS) Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Recruiting

NCT01143480
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older, of any gender
  • People who are able to understand the study information and sign a written consent form
  • People who are able to travel to the Clinical Research Unit (the study location)
  • People who are willing and able to avoid eating or drinking after midnight before their study appointment
  • People who are generally healthy, meaning they feel well and can carry out normal daily activities — including those with a managed chronic condition such as diabetes or high blood pressure, provided it is being treated and is under control

Who may not be able to join:

  • People who have taken anti-inflammatory pain relievers such as ibuprofen (Motrin, Advil) or naproxen within the 5 days before their enrollment visit
  • People who have taken acetaminophen (Tylenol) within the 5 days before their enrollment visit
  • People who have taken cholesterol-lowering medications (statins such as Zocor, Lipitor, or Crestor) within the 30 days before their enrollment visit
  • People who have taken medications that suppress or modify the immune system, including drugs such as Humira, Enbrel, Remicade, Cyclosporin, Azathioprine, or corticosteroids like prednisone
  • People currently receiving chemotherapy or radiation treatment for cancer
  • People with a known or suspected condition that weakens the immune system
  • People who have had a stomach, gut, or breathing illness — including a cold or allergies — within the 5 days before their enrollment visit
  • People who have smoked, chewed tobacco, or used electronic cigarettes within the 2 weeks before their enrollment visit
  • People who have consumed more than 2 standard alcoholic drinks (where one drink contains 15g of alcohol) in the 24 hours before their enrollment visit
  • People who weigh less than 50 kg (110 lbs)
  • People whose temperature, blood pressure, or pulse falls outside the acceptable ranges set by the study (confirm with trial site)
  • People who are pregnant or may be pregnant
  • People who have chronic kidney disease

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael B Fessler, M.D., National Institute of Environmental Health Sciences (NIEHS)

Phone: (855) 696-4347

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Institute of Environmental Health Sciences (NIEHS)
Registry
ClinicalTrials.gov
Start date
30 July 2012

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The primary endpoints of this study are for both cell types and will be levels of 6 cytokines [TNF alpha, IL-6, MIP-2, IL-8, MCP-1, and IFN-beta (ELISA)] induced by LPS and by PAM3CSK4 plus baseline cytokine levels (no exposure to LPS or PAM3CSK...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov